A decrease in the fatal arrhythmias, an increase in ventricular fibrillation threshold, and amelioration of ventricular and supraventricular arrhythmias have been documented with beta-blockers. They decrease early morning platelet aggregation and arrhythmias induced by catecholamines. By doing this, they decrease the early morning peak incidence of heart attack and sudden death.

Страницы: 1 | 2